Live from the NIH registry
Studies recruiting near San Antonio right now
Top 25 of 1,019 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Consultants of Texas — Schertz, Texas (16.5 mi)
· Sponsor: Genentech, Inc.
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Texas Oncology-San Antonio Medical Center — San Antonio, Texas (3.3 mi)
· Sponsor: Kartos Therapeutics, Inc.
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
START — San Antonio, Texas (3.3 mi)
· Sponsor: Revolution Medicines, Inc.
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
KRAS G12C Mutation, KRAS G12S Mutation
Phase 1
Interventional 140 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Kumquat Biosciences Inc.
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Urology San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
Sun Research Institute — San Antonio, Texas (3.3 mi)
· Sponsor: Takeda
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — San Antonio, Texas (3.3 mi)
· Sponsor: Dren Bio
Treatment for PTSD and Tinnitus
PTSD - Post Traumatic Stress Disorder, Posttraumatic Stress Disorder (PTSD)
N/A
Interventional 160 participants sought
The University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
RFSA Dermatology — San Antonio, Texas (3.3 mi)
· Sponsor: Celldex Therapeutics
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 1
Interventional 285 participants sought
NEXT Oncology - San Antonio /ID# 278606 — San Antonio, Texas (3.3 mi)
· Sponsor: AbbVie
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Medical Center Ophthalmology Associates — San Antonio, Texas (3.3 mi)
· Sponsor: Boehringer Ingelheim
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Non-small Cell Lung Cancer, Histiocytic Neoplasm
Phase 1, Phase 2
Interventional 554 participants sought
START San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Institut de Recherches Internationales Servier
PAS-004 in Patients With Advanced Solid Tumors
RAS Mutation, NF1 Mutation
Phase 1
Interventional 48 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Pasithea Therapeutics Corp.
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
The University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Jaeb Center for Health Research
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Element Research Group — San Antonio, Texas (3.3 mi)
· Sponsor: Philip Morris Products S.A.
Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
Breast Cancer Metastatic
Phase 1
Interventional 35 participants sought
Mays Cancer Center, UT Health San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
HNSCC, ESCC
Phase 1
Interventional 150 participants sought
Normunity Investigational Site — San Antonio, Texas (3.3 mi)
· Sponsor: Normunity AccelCo, Inc.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Texas Transplant Institute — San Antonio, Texas (3.3 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Colorectal Cancer, Colorectal Cancer (CRC)
Phase 1
Interventional 80 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Cartography Biosciences
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Texas Oncology - San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Bristol-Myers Squibb
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Southern Star Research Institute — San Antonio, Texas (3.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1, Phase 2
Interventional 499 participants sought
Clinical Trial Site — San Antonio, Texas (3.3 mi)
· Sponsor: Arvinas Inc.
Evaluate the Safety and Clinical Activity of HH2853
FL Lymphoma, Epithelioid Sarcoma
Phase 1, Phase 2
Interventional 254 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Haihe Biopharma Co., Ltd.
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
University of Texas Health Science Center of San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: GT Medical Technologies, Inc.
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Biliary Tract Cancer, Breast Cancer
Phase 1, Phase 2
Interventional 330 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: ModeX Therapeutics, An OPKO Health Company